Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.83ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.310ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.362.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.162ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Y.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.123 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.12.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XRENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.350.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.86ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.154ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.137ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.446ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.76 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.398ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.163ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.3 (Theta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.254ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.39.1.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.418ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.122ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.431ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.168ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.6 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.97ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used